Yet a glut of the compound has now saturated the market to such a degree that prices have plummeted, forcing Chinese drug manufacturers out of business.
Artemisinin is extracted from the sweet wormwood plant Artemisia annua, and China is home to 80–90 per cent of the world’s supply. The World Health Organization (WHO) and Novartis have worked together since 2001 to channel much of that medicine into Africa.
But the sudden increase in demand for artemisinin caused a serious shortage, triggering a massive price rise that peaked at 8000 yuan (£537) per kilogram of artemisinin in 2005. To capitalise on this, the number of Chinese artemisinin producers rose from three in 2004 to more than 80 in 2007.
China’s annual supply of artemisinin now stands at about 150 tonnes per year – roughly six times what Novartis and the WHO are prepared to buy annually. The resulting surplus has caused the market price of artemisinin to plummet to around 1600 yuan (£107) per kilogram, and the crash has already forced some artemisinin producers out of business.
Novartis points out that it is not responsible for the business crisis. ‘We have repeatedly warned Chinese suppliers that the African anti-malaria market is very small due to their low consumption capacity,’ explained a spokesperson for Novartis China. They added that the WHO is unlikely to buy more artemisinin without an increase in funding for their malaria campaign.
Crucially, the Chinese surplus is still not reaching patients in Africa. Only one Chinese firm – Guangxi-based Guilin Pharmaceutical – has obtained WHO approval (in August 2007) to sell artemisinin in Africa, as part of a combination therapy with another drug.
Chinese market analysts blame the Chinese drug regulator for issuing licenses to produce artemisinin too easily, and for failing to close down unauthorised producers. ‘Local governments should be blamed as well,’ Zhou Chengming, president of Beijing-based Shizhen Traditional Chinese Medicine (TCM) Group told Chemistry World. ‘They have exaggerated artemisinin as the great hope for Chinese pharmaceuticals to go abroad.’
The full text of this Chemistry World story is at:
Brian Emsley | alfa
In focus: Peptides, the “little brothers and sisters” of proteins
12.11.2018 | Technische Universität Berlin
How to produce fluorescent nanoparticles for medical applications in a nuclear reactor
09.11.2018 | Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague)
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.
Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
12.11.2018 | Life Sciences
12.11.2018 | Materials Sciences
12.11.2018 | Physics and Astronomy